Red Light Therapy in Thrombosis and Hemostasis

Area of Science:

• Biomedical Engineering
• Hematology
• Photomedicine

Background:

• Red light therapy (photobiomodulation) is investigated for its non-pharmacological effects on thrombosis and hemostasis.
• It influences nitric oxide release, endothelial function, platelet activation, and vascular tone, addressing components of Virchow's triad.
• Potential benefits include reduced platelet aggregation and improved microvascular perfusion, counteracting thromboinflammation.

Purpose of the Study:

• To explore the potential of red light therapy as a non-pharmacological approach to modulate thrombosis and hemostasis.
• To review the mechanisms by which photobiomodulation may impact factors contributing to clot formation.
• To identify challenges and future research directions for clinical implementation.

Main Methods:

• Review of experimental data and existing literature on photobiomodulation (red, NIR, FIR wavelengths) and its effects on hemostatic and thrombotic pathways.
• Analysis of how these effects relate to Virchow's triad and thromboinflammation.
• Consideration of limitations such as tissue penetration and protocol standardization.

Main Results:

• Photobiomodulation influences endothelial function, platelet activity, and vascular tone, potentially reducing platelet aggregation and improving perfusion.
• Observed benefits may relate to direct red/NIR effects or the exclusion of blue light.
• Challenges include standardization, tissue penetration, and translation from experimental models.

Conclusions:

• Red light therapy presents a promising avenue for thrombosis management, particularly in patients at high risk of bleeding with conventional anticoagulation.
• Further research is essential to define optimal parameters, elucidate mechanisms, and validate efficacy through randomized clinical trials.
• Establishing its role in thrombosis management requires rigorous investigation into dosing, pathways, and clinical outcomes.